黄褐斑发病机制及治疗药物的研究进展  

Pathogenesis and Reserch Progress of Therapeutic Drugs of Chloasma

作　　者：杨婷婷[1] 杨国红[1] 王曙光[1] 陈解春[1] 

机构地区：[1]上海现代制药股份有限公司,上海200050

出　　处：《中华中医药学刊》2013年第3期604-606,共3页Chinese Archives of Traditional Chinese Medicine

基　　金：上海市科技创新行动计划2010年度中药现代化专项资助项目(10DZ1970300)

摘　　要：黄褐斑的发病原因及治病机制十分复杂。但近年来随着经济的发展和生活水平的提高,黄褐斑作为一种皮肤病问题越来越引起人们的重视。无论是传统医学还是现代医学都努力寻找一条可行的途径以解决当前难题。The etiology and pathogenesis of melasma are very complex. But in recent years, with the economic development and improvement of living standards, chloasma as a dermatological problem has been paid more and more attentions to. Either traditional medicine or modern medicine is trying to find a feasible way to solve the problem.

关 键 词：黄褐斑 发病机制 治疗药物 

分 类 号：R758.42[医药卫生—皮肤病学与性病学]